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Individual microtubules (MTs) in the axon consist of a
stable domain that is highly acetylated and a labile
domain that is not. Traditional MT-severing pro-
teins preferentially cut the MT in the stable domain.
In Drosophila, fidgetin behaves in this fashion, with
targeted knockdown resulting in neurons with a
higher fraction of acetylated (stable) MT mass in
their axons. Conversely, in a fidgetin knockout
mouse, the fraction of MT mass that is acetylated is
lower than in the control animal. When fidgetin is
depleted from cultured rodent neurons, there is a
62% increase in axonalMTmass, all of which is labile.
Concomitantly, there are more minor processes and
a longer axon. Together with experimental data
showing that vertebrate fidgetin targets unacetylated
tubulin, these results indicate that vertebrate fidgetin
(unlike its fly ortholog) regulates neuronal develop-
ment by tamping back the expansion of the labile
domains of MTs.INTRODUCTION
In the axon, each microtubule (MT) consists of a stable domain
from which can elongate a labile domain (Baas and Black,
1990). The stable and labile domains are situated toward the
minus and plus ends of the MT, respectively, with the labile
portion of the MT directed toward the tip of the axon. For axons
to grow in a robust fashion, theremust be an expansion of theMT
array, and especially of the labile domains. Also important for
axonal growth is a process whereby long MTs are severed into
shorter ones by proteins that tug at the MT lattice to induce
breakage (Roll-Mecak and Vale, 2008). If the breakage occurs
in the stable domain of an MT, the result is two new MTs, both
capable of growing longer. This allows for an increase in MT
number, locally within the axon, for example, at sites of branch
formation (Qiang et al., 2010). If this breakage were to occur inCell Repa labile domain, the expected result would be just one MT that
is shorter than the original, as an MT with no stable domain
would depolymerize completely. Traditional MT-severing pro-
teins, katanin and spastin, preferentially sever MTs in the stable
domain (Riano et al., 2009). In theory, an MT-severing protein
that targets the labile domain could be important for limiting
the expansion of theMT array of the axon tomodulate its growth.
While Drosophila fidgetin (Fgn) is a traditional MT-severing pro-
tein (Zhang et al., 2007), its vertebrate ortholog diverges in
sequence and structure (Yang et al., 2006), and yet is still able
to sever MTs (Mukherjee et al., 2012). Results of our study
indicate that vertebrate Fgn regulates neuronal development
by targeting labile domains of MTs.
RESULTS
Fgn Depletion Affects Axonal Development and MTs in
Drosophila
The effects of knocking down Drosophila Fgn from fly neurons in
the neuromuscular junction (NMJ) were investigated first. The
Gal4/UAS system (Brand and Perrimon, 1993) was used to
express an RNAi hairpin targeting the Drosophila Fgn gene
(CG3326, or Fgn) under UAS control (UAS:Fgn-RNAi). Expres-
sion was limited to post-mitotic neurons using the Elav-gal4
driver (Campos et al., 1987). The total number of synaptic con-
tacts (boutons) was significantly higher in Fgn-knockdown ani-
mals (Figures 1B and 1E) compared to outcrossed control (Ctl)
animals (Figures 1A and 1E). The number of satellite boutons,
which are small growths of presynaptic membranes that extend
out from axonal terminal arbors, in Fgn-knockdown animals
(arrows in Figures 1D and 1E) was greater than that of Ctls (Fig-
ures 1C and 1E). An increased number of satellite boutons has
been observed in flies bearing mutations to other MT-severing
proteins (Sherwood et al., 2004; Mao et al., 2014). A significant
increase in the ratio of acetylated to total tubulin (measured by
quantifying fluorescence intensity) was observed in the axonal
shaft and distal synapse, compared to two independent control
RNAi lines (Ctl1 and Ctl2) (Figure 1F). This was due to a signifi-
cant increase in MT acetylation in these areas, as total tubulin
levels remained relatively unchanged (Figure 1F). A similar resultorts 12, 1723–1730, September 22, 2015 ª2015 The Authors 1723
Figure 1. Drosophila Fgn Knockdown Increases Synaptic Connec-
tions In Vivo
(A–D) Confocal images of third instar larval NMJs, muscles 6 and 7, labeled
with a-HRP (white) to detect presynaptic neuronal membranes. The following
are shown: (A) a Ctl NMJ; (B) an NMJ from an Fgn-knockdown animal
(Dcr2;UAS:Fgn-RNAi;elav-Gal4; note the significant increase in bouton num-
ber in Fgn-knockdown animals compared to Ctls); (C) a representative indi-
vidual bouton from Ctl animals; (D) a bouton with associated satellite boutons
from an Fgn-knockdown animal. Arrows show the bouton; arrowheads show
satellites. Scale bar represents 10 mm.
(E) Quantification of the number of total boutons and satellite boutons in
Fgn-knockdown animals compared to Ctls is shown.
(F) Quantification of IF intensity of acetylated tubulin (top), total tubulin
(middle), and ratio of acetylated to total tubulin (bottom) between Fgn-
knockdown animals (Dcr2;UAS:Fgn-RNAi;elav-Gal4) and outcrossed Ctls
1724 Cell Reports 12, 1723–1730, September 22, 2015 ª2015 The Ahas been reported in Drosophila neurons with compromised
katanin (Mao et al., 2014). These results are consistent with
Drosophila Fgn behaving similarly to traditional MT-severing pro-
teins in the neurons of the fly.
Fgn Expression in Developing Neurons
Fgn was discovered in vertebrates as a gene spontaneously
mutated in a mouse strain that displayed a fidgeting phenotype
(Cox et al., 2000). As shown in Figure 2A, vertebrate Fgn is larger
than Drosophila Fgn, with a region of over 300 amino acids
toward the N terminus that is absent from the fly ortholog. The
Walker A motif in the AAA region is the same as in fly, but the
Walker B has unusual amino acid substitutions. Multiple at-
tempts at developing Fgn antibodies in the past have failed for
unknown reasons (Yang et al., 2005). Here, a line of mice that
knocks out Fgn by replacing most of the Fgn gene for LacZ
was purchased, so that Fgn’s expression pattern could be
observed by staining for b-galactosidase. Fgn expression was
observed in various tissues, but was especially high in devel-
oping nervous tissue (Figure 2B).
Like cultures of fetal rat hippocampal neurons used in relevant
previous studies (Qiang et al., 2010), cortical neurons undergo
stereotyped developmental stages in which a lamellipodium
(stage 1) becomes multiple minor processes (stage 2), one of
which then becomes the axon (stage 3) after which the rest
become dendrites (stage 4). Consistent with previous studies
with mouse GFP-Fgn (Yang et al., 2005), ectopically expressed
rat GFP-Fgn was found to reside in the nucleus, but was also
cytoplasmic, distributing throughout the neuron. The morpho-
logical effects of Fgn overexpression were a shorter axon and
fewer immature processes (Figure 2C and quantification in Fig-
ure 2E). There was no evidence of short fragmented MTs as a
result of Fgn expression. For example, in Figure 2D, long MTs
appear in the growth cone in GFP-Fgn-expressing neurons as
well as Ctl GFP-expressing neurons, without any obvious short
MT fragments. Per unit length of axon, there was no difference
in MT levels in Ctl and Fgn-depleted axons (Figure 2E). Whether
the construct was GFP-Fgn or Fgn-GFP or whether a flag tag
was used, no fragmentation of MTs was observed in neurons
or in rat fibroblasts (Figure S1).
Effects of Fgn Depletion on Cultured Vertebrate
Neurons
Small interfering RNA (siRNA) was introduced just prior
to plating. After 2 days of protein depletion, dense cultures
were re-plated at a lower density to quantify differences in
neuronal morphology when processes were permitted to grow
anew. A day after re-plating, the total number ofminor processes
per cell body was roughly doubled in Fgn-depleted neurons (Fig-
ure 2G) compared to Ctl (Figure 2F), and Fgn-depleted neurons
had significantly longer axons (see also Figure 2H, which shows
tracings of additional Ctl and Fgn-depleted neurons). Differ-
entiation was accelerated as a result of Fgn depletion, with(Dcr2;;elav-Gal4 and UAS:Fgn-RNAi/+) at both the axonal shaft and
distal synapse near the bouton. Note the significant increase of the ratio
of acetylated tubulin to total tubulin. Error bars represent SE. *p < 0.05,
***p < 0.001.
uthors
Figure 2. Studies on Vertebrate Fgn Expression in Rodent Neurons
(A) Amino acid (aa) alignment of Fgn orthologs from rat (759 aa), mouse (759 aa), and Drosophila (523 aa). The two vertebrate orthologs are 99% identical, but
notably different from Drosophila Fgn (see Results).
(B) X-gal staining of Fgn knockout/reporter mouse fetus at E12.5. Fgn is highly expressed in CNS regions, such as brain and eye (left) and spinal cord (right).
(C–E) MT immunostaining (anti-bIII-tubulin antibody) in cortical neurons expressing either GFP or GFP-Fgn. Fgn-overexpressing neurons have statistically shorter
axons (70.04 ± 6.95 mm) and fewer minor processes (3.33 ± 0.163) compared to GFP-expressing Ctl neurons (axon length, 99.44 ± 8.0 mm; minor process
number, 5.22 ± 0.35). Quantification is shown in (E) (Student’s t test, p% 0.05). No difference in growth cone morphology or relative MTmass was observed as a
result of Fgn overexpression (D, left and right). Similarly, there was no significant difference in MTmass in the axon (Student’s t test, pR 0.05; E, third graph from
left) between Ctl GFP (484 ± 69.42 AFU) and Fgn-expressing neurons (552 ± 46.95). Scale bars represent 0.5 mm (B, left), 2 mm (B, right), 10 mm (C, right), and
5 mm (D, right).
(F–J) The effect on cortical neurons of Fgn siRNA pool. (F–H) Immunostains for bIII-tubulin. (F, left) and (G, left) are stage 2 neurons fromCtl and Fgn siRNA groups,
respectively, while (F, right) and (G, right) are stage 3 neurons from the same experimental groups. Fgn depletion increases axon length (158.59 ± 14.90 mm; G,
right and I, right), minor process number (10 ± 0.183; G, left and right and I, left), and rate of polarization (stage 1, 30% ± 5.6%; stage 2, 40% ± 3.5%; stage 3,
31% ± 2.5% (H, left and I, left) compared to Ctl siRNA neurons (F, left and right and H, left; axon length, 102.77 ± 5.95 mm; process number, 6 ± 0.47; polarization
stage 1, 45% ± 4.4%; stage 2, 42% ± 3.5%; stage 3, 14% ± 1.7%) (Student’s t test p% 0.05). Quantification is shown in (I). Validation of Fgn siRNA is shown in (J)
where RFL-6 cells were co-transfected with GFP-Fgn and either Ctl siRNA (left) or Fgn siRNA (right). Fgn siRNA reduced (Student’s t test, pR 0.05) by more than
70% the GFP-Fgn expression observed with Ctl siRNA, as evaluated by western blotting (fold change: Ctl siRNA, 1 ± 0.104; Fgn siRNA, 0.28 ± 0.194; J and
immunocytochemistry [data not shown]). Scale bars represent 20 mm (F, right) and 50 mm (H, right).
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Figure 3. Vertebrate Fgn Depletion In-
creases Labile MT Mass in the Axon but
Does Not Alter MT Number
(A) Cortical neurons that had been treated for 48 hr
with Fgn or Ctl siRNA and then re-plated were
treated with nocodazole (0.2 mg/ml) for 0 min,
30 min, or 4 hr. Cultures were pre-extracted to
release free tubulin and then prepared for IF or
western blotting. Fgn-depleted cultures had
52.75% ± 8.9% greater MT mass compared to Ctl
siRNA (one-way ANOVA, p% 0.05). At 30-min no-
docazole, MTmass decreased to roughly half (one-
way ANOVA, p % 0.05) compared to the nocoda-
zole-free time point (Ctl siRNA, 45.21% ± 1.21%
decrease; Fgn siRNA, 54.71%± 15.92%decrease),
with no difference in MT levels between the Ctl
siRNAandFgnsiRNAgroups (one-wayANOVA, p >
0.05). Fgn-depleted cultures and Ctl cultures also
did not differ in MT mass (one-way ANOVA, p R
0.05) after 4 hr in nocodazole (Ctl siRNA, 31.97% ±
5.46%; Fgn siRNA, 34.78% ± 10.27%). Quantifi-
cation of MT mass in the axon was by IF.
(B) Fgn depletion increases the overall MT mass
in the axon by 62% (Ctl siRNA, 327.09 ± 28.26;
Fgn siRNA, 530.55 ± 34.88; one-way ANOVA,
p% 0.05). No differences were observed (one-way
ANOVA, p R 0.05) between Fgn siRNA and Ctl
siRNA after treatment with nocodazole (0.2 mg/ml)
for 30 min (Ctl siRNA, 150.34 ± 11.84; Fgn siRNA,
167.36 ± 17.66).
(C) Neurons were transfected at day 0 with Fgn or Ctl siRNA and re-transfected with EB3-GFP at the time of re-plating, so that dynamic plus ends of MTs could
be visualized as fluorescent comets (tracked as 1 frame/s) during bouts of MT assembly. The two experimental groups did not differ (Student’s t test, pR 0.05) in
terms of comet number (Ctl siRNA, 44.70 ± 14.43; Fgn siRNA, 47.40 ± 14.39), duration (Ctl siRNA, 10.35 ± 0.46 s; Fgn siRNA, 10.82 ± 0.33 s), or speed (Ctl
siRNA, 0.25 ± 0.0073 mm/s; Fgn siRNA, 0.23 ± 0.0098 mm/s).
(D) Schematic shows interpretation of data. Drosophila Fgn behaves similarly to spastin or katanin, targeting the stable domain of axonal MTs. Knockdown
causes an increase in the proportion of the MT that is stable, without altering the length of the MT. Vertebrate Fgn targets the labile domain of axonal MTs, such
that knocking down vertebrate Fgn increases the length of the labile domain.Fgn-depleted cultures at 24 hr having a significantly higher
percentage of neurons in stage 3 compared to Ctl siRNA, and
a corresponding reduction in the percentage of neurons in
stage 1 was observed. Morphological effects of Fgn depletion
were essentially the inverse of the effects resulting from overex-
pression. Data are shown in Figure 2I. For confirmation of knock-
down, GFP-Fgn was expressed in fibroblasts or neurons
together with the siRNA for 24 hr. In western blot analyses,
the GFP-Fgn band, detected with a GFP antibody, was reduced
by over 70% in the cultures transfected with Fgn siRNA
compared to those transfectedwith Ctl siRNA (Figure 2J). Similar
results were obtained on cultures in which each of the siRNA se-
quences was used individually (Figure S2).
Fgn Depletion Increases Labile MT Mass in Axons
In neurons depleted of Fgn, there was a 53% ± 8.9% increase in
MT mass relative to Ctls as assessed by western blotting (Fig-
ure 3A), and a 62% ± 8.63% increase in MT mass per unit area
of axon as assessed by quantitative immunofluorescence (IF)
(Figure 3B). Nocodazole sensitivity was used to discern the sta-
ble and labile fractions of the MT mass (Baas and Black, 1990).
After 30 min of drug treatment, the MT levels were indistinguish-
able from the corresponding drug-treated Ctls, as assessed by
either western blotting or IF (Figures 3C and 3D), indicating1726 Cell Reports 12, 1723–1730, September 22, 2015 ª2015 The Athat the MT mass added as a result of Fgn depletion is entirely
labile.
GFP-EB3 (which tracks dynamic plus ends of MTs) was
expressed at the time of re-plating in neurons that had been
transfected 2 days earlier with either Fgn or Ctl siRNA. No differ-
ence in the number of the GFP-EB3 comets was found between
Fgn-depleted and Ctl axons, nor were there any differences in
the rate or duration of the comets (Figure 3C). These results, in
conjunction with the results of the nocodazole study, suggest
that Fgn depletion does not increase MT number and, therefore,
must lengthen the labile domains of MTs (Figure 3D). By
contrast, knockdown of Drosophila Fgn did not increase MT
levels but resulted in a higher proportion of the MTs being acet-
ylated (Figure 3D).
Fgn Depletion Decreases Ratio of Acetylated to Total
Tubulin in the Axon
Cultures (Ctl-siRNA or Fgn-siRNA) double-labeled for IF visuali-
zation of total or acetylated tubulin in MTs revealed that total MT
levels were elevated in the Fgn-depleted cultures, but acetylated
MT levels remained roughly the same as in Ctl neurons (Fig-
ure 4A). This same reduction in the ratio of acetylated to total
tubulin relative to Ctls was observed by western blotting of the
cultured neurons (Figure 4B) and by immunohistochemistry onuthors
embryonic day (E)18.5 brain of the Fgn knockout/reporter mouse
(Figures 4C–4F).
To investigate whether Fgn could be specifically targeting
unacetylated tubulin, the same morphological experiments
described earlier were conducted in the presence of tubacin,
an inhibitor of HDAC6, the principal tubulin deacetylase in
vertebrate cells (Sudo and Baas, 2010). Higher concentrations
of tubacin can alter neuronal morphology, which is not unex-
pected given that the acetylation status of the MT affects how
it interacts with a variety of different MT-related proteins. Chosen
here was a lower concentration of the drug that had no statisti-
cally significant effect on axon length or process number, relative
to DMSO (vehicle)-treated Ctls. However, even at this low
dosage, there was an increase in tubulin acetylation as assessed
by IF (ratio imaging of acetylated to total tubulin; Figure 4G) and
western blotting (Figure 4H). Treatment of neurons with this dose
of tubacin prevented Fgn siRNA from increasing axon length or
minor process number relative to Ctl siRNA (Figure 4I, upper
graphs), and it prevented overexpression of Fgn from reducing
axon length and process number (Figure 4J).
Because acetyl transferases and deacetylases do not exclu-
sively affect tubulin and may have other effects on MTs apart
from their acetylation status, another approach was taken to
further investigate. The chief tubulin acetyl transferase in verte-
brate cells, namely a-TAT1 (Shida et al., 2010), was overex-
pressed. A mutant form of a-TAT1 (called a-TAT1 D157N) that
cannot acetylate tubulin, but presumably can do anything else
a-TAT1 may do, was used as a Ctl. Validation of the wild-type
construct, but not the mutant, to increase MT acetylation is
shown in Figure 4H. These constructs were transfected as
GFP fusions into fetal cortical neurons just prior to re-plating
neurons that had been transfected with Fgn siRNA 2 days prior.
Then, 2 days later, the lengths of the axons and the number of
minor processes from neurons expressing the constructs were
quantified. Consistent with the tubacin results, both the increase
in axon length and minor process number resulting from Fgn
depletion were preserved in the presence of a-TAT1 D157N
but were obliterated by the wild-type a-TAT1. Quantification of
these results is shown in Figure 4I (lower graphs). Together,
these and the tubacin results indicate that morphological
changes resulting from increasing or decreasing the levels of
Fgn depend on the presence of poorly acetylated MT domains.
DISCUSSION
The present results indicate that vertebrate Fgn functions during
development to tamp back the elongation of the labile domains
ofMTs so that they assemble in a regulated fashion. Overexpres-
sion of vertebrate Fgn does not result in obvious loss of MT
mass from cells in which the labile domains are not expanding,
but does suppress normal axonal elongation, a process that
depends on the expansion of labile domains. Accordingly,
depletion of vertebrate Fgn results in longer labile MT domains
and longer axons. Changes in process number resulting from
alterations in Fgn levels also can be explained this way. The sit-
uation is different in Drosophila, where the data suggest that Fgn
functions as a traditional MT-severing protein, preferentially
severing stable MT domains. Unlike flies, which only have oneCell RepFgn gene, vertebrates have two Fgn-like genes (Cox et al.,
2000), which may have allowed Fgn itself to diverge. Vertebrate
axons are much longer than Drosophila axons, which may be
why vertebrates evolved machinery dissimilar from flies for regu-
lating the growth capacity of the axon.
As for a mechanism, an initial idea was that vertebrate Fgn
might co-hexamerize or co-dimerize with spastin and thereby
act as a dominant-negative to spastin’s function. This idea
came to mind because the phenotype of Fgn knockdown is
similar to that of spastin overexpression, especially with regard
to higher numbers of minor processes (Yu et al., 2008). Another
idea is that the unique properties of vertebrate Fgn may result
from the N-terminal domain of vertebrate Fgn absent from
invertebrate orthologs acting in a regulatory fashion, similar to
the situation with certain kinesins, where an inhibitory domain
can fold over to suppress the activity of the functional domain
(Cross and Scholey, 1999). However, neither of these ideas
easily explains how Fgn preferentially severs labile domains of
MTs. To this point, perhaps the amino acid substitutions in the
Walker B domain weaken the ATPase activity such that verte-
brate Fgn is only strong enough to break the lattice of the MT
where it is weakest. This could result in a preference for the
region of the MT toward its plus end, where much of the lattice
has not yet fully closed. However, this would contrast with
in vitro data suggesting that vertebrate Fgn has a preference
for minus ends of MTs (Mukherjee et al., 2012). The present
results support another possibility, namely that vertebrate Fgn
targets labile domains of MTs through a preference for unacety-
lated tubulin. This idea is appealing because it would make Fgn
the functional inverse of katanin, which targets stable domains
through a preference for acetylated tubulin (Mao et al., 2014;
Sudo and Baas, 2010).
Finally, there is the potential for therapeutic application. Inhi-
bition of Fgn might be useful for treating neurodegenerative
diseases as well as nerve injury, as a boost in labile MT mass
may restore lost MT mass and/or enable a regenerating axon
to grow with more vitality (Baas and Ahmad, 2013).
EXPERIMENTAL PROCEDURES
Fgn Conditional Knockdown Flies
Transgenic fly lines UAS:CG3326-RNAi (abbreviated as UAS:Fgn-RNAi here)
were obtained from the Vienna Drosophila Resource Center (stock 24746).
RNAi expression was restricted to neurons by using the Elavc155-Gal4 driver
(Robinow and White, 1991). Abdominal segment A3 from muscle 6/7 of third
instar larvae was used for NMJ analysis. Immunohistochemistry was per-
formed as previously described (Ghosh et al., 2014). Primary antibodies
were as follows: anti-bIII-tubulin (BioLegend) specific for neurons and anti-
acetylated tubulin (Sigma). Fluorescently conjugated a-HRP (1:125, Jackson
ImmunoResearch Laboratories) was used to visualize neuronal membranes.
NMJ images were obtained using an Olympus Fluoview 1000 laser-scanning
confocal microscope.
Fgn Knockout/Reporter Mouse
An Fgn knockout/reporter mouse (strain name: B6.129-Figntm1Frk/Frk) in
which a b-galactosidase reporter gene was inserted into the Fgn gene,
replacing its catalytic domain (Cox et al., 2000), was purchased from Jack-
son Laboratory. Heterozygotes are fertile, while homozygotes die prenatally.
X-gal staining of homozygote fetuses was conducted at E12.5. Brain
immunohistochemistry for bIII-tubulin and acetylated tubulin was performed
on homozygote fetuses at E18.5 (sagittal 20-mm sections) with the sameorts 12, 1723–1730, September 22, 2015 ª2015 The Authors 1727
Figure 4. Fgn Is Sensitive to Acetylation Status of MTs in the Axon
(A) Ratio images of acetylated tubulin to total bIII-tubulin displayed in fire-scale pseudo-color (white being the highest intensity and red being the lowest). Fgn
siRNA neurons (right) display a decrease of acetylated to total tubulin ratio compared to Ctl siRNA.
(B) Same result by western blot analysis with (right) quantification indicating that Ctl siRNA cultures have a higher ratio of acetylated to total tubulin compared to
Fgn siRNA (fold change: Ctl siRNA, 2.1 ± 0.29; Fgn siRNA, 1; Student’s t test, p% 0.05).
(C–E) Brain immunohistochemistry of acetylated tubulin (C, left and right) and total bIII-tubulin (D, left and right) from E18.5 wild-type mouse and Fgn knockout/
reporter mouse, respectively. Knockout brain has a decreased ratio of acetylated to total tubulin (E, right) compared to wild-type (E, left).
(F) Quantification is shown as fold change normalized to the value of Fgn knockout ratio value as 1. Such difference was observed in all brain areas analyzed (the
ratio value for the wild-type mouse are as follows: olfactory bulb, 2.2; cortex, 2.2; septum, 1.31; thalamus, 2.6; and pretectum, 1.9).
(G) Ratio images in fire-scale pseudo-color of neurons treated with 2.5 mM tubacin or DMSO vehicle (Ctl) and immunostained for acetylated tubulin and total
tubulin. The ratio of acetylated to total tubulin is higher with tubacin treatment.
(H) (Top) Western blotting of parallel cultures also show an increase in acetylated tubulin. (Bottom) RFL-6 fibroblasts prepared for IF visualization of acetylated
tubulin after overnight expression of an enzymatically inactive mutant of aTAT-1 (called aTAT-1 D157N) or the wild-type aTAT-1. Wild-type aTAT-1 shows higher
staining intensity of acetylated MTs than the mutant. Similar results were obtained on neurons (data not shown).
(I) Morphological quantification of experiments similar to those from Figure 2, except that MT acetylation was manipulated by either tubacin treatment or aTAT-1
overexpression. Ctl for the former and latter were DMSO vehicle and the aTAT-1 D157N, respectively. Neurons depleted of Fgn treated with vehicle (DMSO) have
significantly longer axons (175 ± 11.04 mm; p % 0.05, one-way ANOVA) and a higher number of minor processes (10 ± 0.9;1 p % 0.05, one-way ANOVA)
compared to DMSO Ctl siRNA neurons (average axon length, 105 ± 8.29 mm; process number, 5 ± 0.49). With tubacin treatment, there were no morphological
differences between Ctl (average axon length, 117 ± 6.80 mm; process number, 4.85 ± 0.37) and Fgn siRNA (average axon length, 117 ± 9.00 mm; process
number, 6.26 ± 0.64; p > 0.05, one-way ANOVA for both measurements). Neurons depleted of Fgn expressing aTAT-1 D157N have longer axons (146 ± 9.78 mm;
(legend continued on next page)
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antibodies used for the fly studies. Images were acquired with the confocal
Leica TCS SP2 VIS/405.
DNA Constructs and siRNA
The mEmerald-Fgn (termed GFP-Fgn, as mEmerald is a modified GFP) and
FLAG-Fgn were generated from rat Fgn (NM_001106484.1). Fgn-GFP and
EB3-GFPwereprovidedbyW.FrankelandN.Galjart, respectively.GFP-spastin
wasgeneratedasdescribedpreviously (Qianget al., 2010). Thea-TAT1 (pEF5B-
FRT-GFP-a-TAT1) and a-TAT1 D157N (pEF5B-FRT-GFP-a-TAT1 [D157N])
were from Addgene. For siRNA experiments, cells were transfected with a
pool of four rat Fgn sequences (Sigma-Aldrich, NCBI Reference Sequence
(RefSeq): NM_001106484.1) or with a non-specific Ctl sequence (Ambion,
AM4636), using the nucleofector device from Amaxa as previously described
(Yu et al., 2008). The four sequences that comprise the pool also were used
individually. The siRNA was used at 10 mM. DNA constructs were transfected
by nucleofection into neurons or with Lipofectamine 2000 into fibroblasts.
Cultured Rat Fetal Cortical Neurons
For MT quantification studies, cultures were pre-extracted in an MT-stabilizing
buffer to release free tubulin as described previously, except that the detergent
was 0.1% Triton X-100, prior to further processing for IF or western blotting
(Baas and Black, 1990). Analyses were performed after 0 min, 30 min, or 4 hr
in 2 mg/ml nocodazole or DMSO control (Baas and Black, 1990). For all other
IF preparations, cells were fixed in 4% paraformaldehyde (PFA) and then
post-extracted with 0.1% Triton. Images were acquired using identical expo-
sure and other settings, thus allowing the comparisons between experimental
groups. Ratio images of cultured neurons were obtained using the Zeiss Axio-
vert LSM 5 Pascal system with a HeNe laser microscope with no optical
sectioningduring imagingacquisition.Westernblottingwasperformedby stan-
dardprocedures, except that for theMTquantificationexperiments, the internal
controlwashistoneH3 level becauseGAPDHwas lost during thepre-extraction
step required to release free tubulin. Axon length was measured using Axiovi-
sion 4.6 software, considering as an axon anyprocess longer than 50mm.Minor
processes were considered as any process longer than 6 mm but shorter than
50 mm. Developmental stages were defined as described in the Results. For
Fgndepletion studies,more than 100cells per conditionper trialwere analyzed.
For overexpression studies, 30 cells per condition were analyzed in each trial.
EB3 imaging was as previously described (Qiang et al., 2010). Three indepen-
dent trials were performed for each analysis. For MT acetylation studies, tuba-
cin was used at 2.5 mM and the a-TAT1 constructs were used as previously
described (Shida et al., 2010). Three independent trials were performed in
each study, and an average of at least 100 neurons per condition per trial
were taken during the quantification. For some experiments, RFL-6, a rat fibro-
blast cell line, was used in addition to the primary cortical neurons.
Statistical Analyses
All of the data analyses, statistical comparisons, and graphs were obtained by
using SPSS 20 (IBM) and Excel (Microsoft). Data represent, if not otherwise
specified, mean ± SD. Mean difference was considered to be significant at
the 0.05 level (*p % 0.05). Multiple group comparison was performed by
one-way ANOVA followed by Bonferroni post hoc, and for pair comparison,
Student’s t test.
Institutional Review Board Approval
Rats and mice were used for the present studies under supervision and over-
sight from the Institutional Animal Care and Use Committees (IACUC) at Drexel
University and Albert Einstein University College of Medicine.p% 0.05, one-way ANOVA) and a higher number of minor processes (10 ± 0.86
(average axon length, 96 ± 8.62 mm; process number, 6 ± 0.63). With aTAT-1 ex
length, 98 ± 8.80 mm; process number, 6 ± 0.71) and Fgn siRNA (average axon le
both measurements).
(J) The effects on morphology when GFP-Fgn-overexpressing neurons were treat
with vehicle (DMSO) show reduced minor process number (3.4 ± 0.27) and axon
absence of tubacin (minor process numbers, 5.1 ± 0.38 and 4.8 ± 0.38, respectiv
ANOVA). Scale bars represent 10 mm (A, left and G, right) and 100 mm (B, left). *p
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